United States · biotech/health
United States · biotech/healthCerebral Therapeutics
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
PrivateFor profit
Against its peers
Set against 435 biotech/health companies in United States. The ring marks the typical peer.
Across all 5.9M companies: larger than 0% of those with a size listed; older than 5% of those with a founding year; website ranked #8,656,048 in the world, about 486 visits a month.
About Cerebral Therapeutics
BiotechnologyHealth CarePharmaceuticalTherapeutics
Funding, as listed
What the source datasets report. We have not watched these rounds ourselves.
$86M
raised in total, currency not stated across 4 rounds
Last raised Jun 2022, 4 years ago
- Rounds
- 4
- Latest round
- Series c
- Investors
- 54 leading
Key facts
Who started it and how it trades.
- Founded by
- Daniel J. Abrams
Every detail we hold
Everything the source datasets list about Cerebral Therapeutics, field by field. Contact details are held but never shown.
The company7 fields
- Name
- Cerebral Therapeutics
- Type
- For profit
- Status
- Private
- Founded
- 2010
- Founders
- Daniel J. Abrams
- Industry
- biotech/health
- Categories
- Biotechnology, Health Care, Pharmaceutical, Therapeutics
Where3 fields
- City
- Aurora
- Country
- United States
- Markets
- Greater Denver Area, Western US
Size and reach3 fields
- Staff band
- 1-10
- Web traffic rank
- #8,656,048
- Monthly web visits
- 486
Show 9 more fieldsShow fewer fields
Funding, as listed7 fields
- Total
- 85,800,000 (currency not stated)
- Rounds
- 4
- Latest round
- Series c
- Latest round date
- Jun 2022
- Investors
- 5
- Lead investors
- 4
- Listing status
- private
About this record2 fields
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Cerebral Therapeutics may be growing as it is listed among key players in a market that is expected to increase at a steady growth rate by 2032 according to a report by DelveInsight. Being recognized as a key player suggests that the company has a significant presence and potential influence in the Lennox-Gastaut Syndrome market. The inclusion in this report indicates that Cerebral Therapeutics is considered an active and notable entity within the biotechnology and pharmaceutical industry, which is typically associated with ongoing business activities and a trajectory of growth.
Companies like Cerebral Therapeutics
biotech/health in United States.
Revolution MedicinesRedwood City · 251-500 peoplefounded 5 years later
FreenomeSouth San Francisco · 501-1000 peoplefounded 4 years later
Relay TherapeuticsCambridge · 251-500 peoplefounded 6 years later
Denali TherapeuticsSan Francisco · 251-500 peoplefounded 3 years later
SpringWorks TherapeuticsStamford · 251-500 peoplefounded 7 years laterBuild a lead list
435 biotech/health companies in United States, filtered by size, age and reach, ready to export with emails on Pro.